SC-51322 Chemical Properties

Melting point:

112-114°C

RTECS 

HQ4002000

storage temp. 

Store at +4°C

solubility 

DMSO: ≥10mg/mL

form 

powder

color 

white to off-white

Safety Information

Hazard Codes 

T

Risk Statements 

25

Safety Statements 

45

RIDADR 

UN 2811 6.1 / PGIII

WGK Germany 

3

HazardClass 

6.1

SC-51322 Usage And Synthesis

Description

The prostaglandin E₂ (PGE₂) receptor (EP₁) is involved in triggering PGE₂-mediated pain as well as neuronal survival and growth. SC-51322 is a selective EP₁ antagonist that inhibits PGE₂ signaling in a guinea pig ileum muscle strip assay with a pA₂ value of 8.1 and demonstrates analgesic activity in a mouse writhing assay with an ED₅₀ value of 0.9 mg/kg. It is pharmacologically similar to SC-51089, but does not release hydrazine, a known carcinogen to rats, as does SC-51089. SC-51322 potentiates the vasorelaxation of human pulmonary vein induced by PGE₂ with an EC₅₀ value of 7.75 μM.

Chemical Properties

Off-White Solid

Uses

A selective E-prostanoid receptor subtype 1 (EP1) receptor antagonist which shows antihypertensive effects.

storage

Store at -20°C

SC-51322(146032-79-3)Related Product Information

• 13,14-DIHYDROPROSTAGLANDIN E1
• PROSTAGLANDIN F1ALPHA
• Latanoprost
• Misoprostol Acid
• PROSTAGLANDIN D2
• Sulprostone
• PROSTAGLANDIN B1
• Fluprostenol
• Prostaglandin F2a
• PROSTAGLANDIN A1
• PROSTAGLANDIN B2
• SC-51089
• U-75302
• L-161,982
• 6(R)-(4-CARBOXYPHENYLTHIO)-5(S)-HYDROXY-7(E),9(E),11(Z),14(Z)-EICOSATETRAENOIC ACID
• 11BETA-PROSTAGL AND IN F2ALPHA
• LEUKOTRIENE B4 DIMETHYL AMIDE
• LEUKOTRIENE D4